The Discounted Cash Flow (DCF) valuation of IRadimed Corp (IRMD) is 104.43 USD. With the latest stock price at 71.46 USD, the upside of IRadimed Corp based on DCF is 46.1%.
Based on the latest price of 71.46 USD and our DCF valuation, IRadimed Corp (IRMD) is a buy. buying IRMD stocks now will result in a potential gain of 46.1%.
Range | Selected | |
WACC / Discount Rate | 4.7% - 6.5% | 5.6% |
Long-term Growth Rate | 3.0% - 4.5% | 3.7% |
Fair Price | 59.01 - 746.86 | 104.43 |
Upside | -17.4% - 945.1% | 46.1% |